Application 204275
- Type
- NDA
- Sponsor
- GLAXO GRP LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | POWDER;INHALATION | 0.1MG/INH;EQ 0.025MG BASE/INH | Yes | Yes |
| 002 | BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | POWDER;INHALATION | 0.2MG/INH;EQ 0.025MG BASE/INH | Yes | Yes |
| 003 | BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | POWDER;INHALATION | 0.05MG/INH;EQ 0.025MG BASE/INH | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204275-001 | BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | |
| N204275-002 | BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | |
| N204275-003 | BREO ELLIPTA | FLUTICASONE FUROATE; VILANTEROL TRIFENATATE | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2023-05-12 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204275-001 | 8511304 | 2027-06-14 | U-1424 | Drug product | 2013-09-06 |
| N204275-001 | 8511304 | 2027-06-14 | U-1691 | Drug product | 2013-09-06 |
| N204275-001 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2013-09-06 |
| N204275-001 | 8511304*PED | 2027-12-14 | Pediatric extension | ||
| N204275-001 | 11116721 | 2029-02-26 | U-1401 | Drug product | 2021-10-12 |
| N204275-001 | 11116721 | 2029-02-26 | U-1691 | Drug product | 2021-10-12 |
| N204275-001 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2021-10-12 |
| N204275-001 | 11116721*PED | 2029-08-26 | Pediatric extension | ||
| N204275-001 | 8534281 | 2030-03-08 | Drug product | 2013-09-18 | |
| N204275-001 | 8534281*PED | 2030-09-08 | Pediatric extension | ||
| N204275-001 | 8746242 | 2030-10-11 | Drug product | 2014-07-08 | |
| N204275-001 | 8746242*PED | 2031-04-11 | Pediatric extension | ||
| N204275-002 | 8511304 | 2027-06-14 | U-1691 | Drug product | 2015-05-07 |
| N204275-002 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2015-05-07 |
| N204275-002 | 8511304*PED | 2027-12-14 | Pediatric extension | ||
| N204275-002 | 11116721 | 2029-02-26 | U-1691 | Drug product | 2021-10-12 |
| N204275-002 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2021-10-12 |
| N204275-002 | 11116721*PED | 2029-08-26 | Pediatric extension | ||
| N204275-002 | 8534281 | 2030-03-08 | Drug product | 2015-05-07 | |
| N204275-002 | 8534281*PED | 2030-09-08 | Pediatric extension | ||
| N204275-002 | 8746242 | 2030-10-11 | Drug product | 2015-05-07 | |
| N204275-002 | 8746242*PED | 2031-04-11 | Pediatric extension | ||
| N204275-003 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2023-06-09 |
| N204275-003 | 8511304*PED | 2027-12-14 | Pediatric extension | ||
| N204275-003 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2023-06-09 |
| N204275-003 | 11116721*PED | 2029-08-26 | Pediatric extension | ||
| N204275-003 | 8534281 | 2030-03-08 | Drug product | 2023-06-09 | |
| N204275-003 | 8534281*PED | 2030-09-08 | Pediatric extension | ||
| N204275-003 | 8746242 | 2030-10-11 | Drug product | 2023-06-09 | |
| N204275-003 | 8746242*PED | 2031-04-11 | Pediatric extension |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N204275-001 | NPP | 2026-05-13 |
| N204275-001 | PED | 2026-11-13 |
| N204275-003 | NS | 2026-05-13 |
| N204275-003 | PED | 2026-11-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2023-05-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2023-05-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204275-002 | BREO ELLIPTA | 0.2MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2015-04-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204275-003 | BREO ELLIPTA | 0.05MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD | 2023-05-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204275-001 | BREO ELLIPTA | 0.1MG/INH;EQ 0.025MG BASE/INH | POWDER / INHALATION | RLD, RS | 2013-05-10 | 1e350fbaab3a… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8511304 | 2027-06-14 | U-1691 | Drug product | 2013-09-06 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8511304 | 2027-06-14 | U-1424 | Drug product | 2013-09-06 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2013-09-06 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8511304*PED | 2027-12-14 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 11116721 | 2029-02-26 | U-1401 | Drug product | 2021-10-12 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2021-10-12 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 11116721 | 2029-02-26 | U-1691 | Drug product | 2021-10-12 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 11116721*PED | 2029-08-26 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8534281 | 2030-03-08 | Drug product | 2013-09-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8534281*PED | 2030-09-08 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8746242 | 2030-10-11 | Drug product | 2014-07-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | 8746242*PED | 2031-04-11 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2015-05-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8511304 | 2027-06-14 | U-1691 | Drug product | 2015-05-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8511304*PED | 2027-12-14 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2021-10-12 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 11116721 | 2029-02-26 | U-1691 | Drug product | 2021-10-12 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 11116721*PED | 2029-08-26 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8534281 | 2030-03-08 | Drug product | 2015-05-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8534281*PED | 2030-09-08 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8746242 | 2030-10-11 | Drug product | 2015-05-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-002 | 8746242*PED | 2031-04-11 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2023-06-09 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 8511304*PED | 2027-12-14 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2023-06-09 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 11116721*PED | 2029-08-26 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 8534281 | 2030-03-08 | Drug product | 2023-06-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 8534281*PED | 2030-09-08 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 8746242 | 2030-10-11 | Drug product | 2023-06-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | 8746242*PED | 2031-04-11 | Pediatric extension | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 8511304 | 2027-06-14 | U-1691 | Drug product | 2013-09-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 8511304 | 2027-06-14 | U-1424 | Drug product | 2013-09-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 8511304 | 2027-06-14 | U-3623 | Drug product | 2013-09-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 8511304*PED | 2027-12-14 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 11116721 | 2029-02-26 | U-1401 | Drug product | 2021-10-12 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 11116721 | 2029-02-26 | U-3623 | Drug product | 2021-10-12 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 11116721 | 2029-02-26 | U-1691 | Drug product | 2021-10-12 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 11116721*PED | 2029-08-26 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 8534281 | 2030-03-08 | Drug product | 2013-09-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | 8534281*PED | 2030-09-08 | Pediatric extension | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | NPP | 2026-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-001 | PED | 2026-11-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | NS | 2026-05-13 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204275-003 | PED | 2026-11-13 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | NPP | 2026-05-13 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-001 | PED | 2026-11-13 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-003 | NS | 2026-05-13 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N204275-003 | PED | 2026-11-13 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-001 | NPP | 2026-05-13 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-001 | PED | 2026-11-13 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-003 | NS | 2026-05-13 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204275-003 | PED | 2026-11-13 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-001 | NPP | 2026-05-13 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-001 | PED | 2026-11-13 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-003 | NS | 2026-05-13 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N204275-003 | PED | 2026-11-13 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-001 | NPP | 2026-05-13 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-001 | PED | 2026-11-13 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-003 | NS | 2026-05-13 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204275-003 | PED | 2026-11-13 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-001 | NPP | 2026-05-13 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-001 | PED | 2026-11-13 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-003 | NS | 2026-05-13 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204275-003 | PED | 2026-11-13 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-001 | NPP | 2026-05-13 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-001 | PED | 2026-11-13 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-003 | NS | 2026-05-13 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204275-003 | PED | 2026-11-13 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-001 | NPP | 2026-05-13 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-001 | PED | 2026-11-13 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-003 | NS | 2026-05-13 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204275-003 | PED | 2026-11-13 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-001 | NPP | 2026-05-13 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-001 | PED | 2026-11-13 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-003 | NS | 2026-05-13 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204275-003 | PED | 2026-11-13 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-001 | NPP | 2026-05-13 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-001 | PED | 2026-11-13 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-003 | NS | 2026-05-13 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204275-003 | PED | 2026-11-13 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fluticasone Furoate and Vilanterol | FLUTICASONE FUROATE AND VILANTEROL | Prasco Laboratories | 3a761487-c300-451a-8537-3196c00c11b5 | 2024-11-21 | Warnings, Adverse reactions | 204275 NDA204275 66993-135 66993-136 |
| Breo Ellipta | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | GlaxoSmithKline LLC | 96428df1-ea05-431a-98d3-1ec2c4b63878 | 2024-11-07 | Warnings, Adverse reactions | 204275 NDA204275 0173-0859 0173-0882 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0173-0859 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0859 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0859 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0859 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0859 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0882 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0882 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0882 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0882 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 0173-0882 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | GlaxoSmithKline LLC | NDA | Current |
| 50090-2404 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | A-S Medication Solutions | NDA | Current |
| 66993-135 | Fluticasone Furoate and Vilanterol | fluticasone furoate and vilanterol | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-136 | Fluticasone Furoate and Vilanterol | fluticasone furoate and vilanterol | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | REMEDYREPACK INC. | NDA | Current |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | REMEDYREPACK INC. | NDA | Current |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | REMEDYREPACK INC. | NDA | Current |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | REMEDYREPACK INC. | NDA | Current |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | REMEDYREPACK INC. | NDA | Current |
| 70518-2028 | Breo Ellipta | fluticasone furoate and vilanterol trifenatate | REMEDYREPACK INC. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 74250 | SUPPL | 2023-05-15 |
| 74241 | SUPPL | 2023-05-15 |
| 57538 | SUPPL | 2019-02-13 |
| 57129 | SUPPL | 2019-01-08 |
| 50879 | SUPPL | 2017-12-27 |
| 50842 | SUPPL | 2017-12-22 |
| 48403 | SUPPL | 2017-05-17 |
| 48387 | SUPPL | 2017-05-17 |
| 45804 | SUPPL | 2016-11-04 |
| 45776 | SUPPL | 2016-11-02 |
| 40370 | SUPPL | 2016-02-18 |
| 32536 | SUPPL | 2016-02-18 |
| 40369 | SUPPL | 2015-09-23 |
| 32535 | SUPPL | 2015-09-16 |
| 40368 | SUPPL | 2015-05-04 |
| 32534 | SUPPL | 2015-05-04 |
| 19540 | SUPPL | 2015-03-05 |
| 10315 | SUPPL | 2015-03-03 |
| 22949 | ORIG | 2013-06-10 |
| 19539 | ORIG | 2013-05-14 |
| 32533 | ORIG | 2013-05-13 |